🇺🇸 FDA
Pipeline program

HellenCare

NBJ-01

Unknown other active

Quick answer

HellenCare for Alzheimer's Disease Dementia is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Alzheimer's Disease Dementia
Phase
Unknown
Modality
other
Status
active

Clinical trials